- Filed
- Apr 22, 2025 12:00 AM ET
- Period of report
- —
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2025 · Mar 31, 2025 | 1.34B sh |
| Short Term Debt | Q1 2025 · Mar 31, 2025 | $212M |
| Short Term Debt | Q1 2025 · Dec 31, 2024 | $183M |
| Stockholders Equity | Q1 2025 · Mar 31, 2025 | $61.52B |
| Stockholders Equity | Q1 2025 · Dec 31, 2024 | $60.16B |
| Current Liabilities | Q1 2025 · Mar 31, 2025 | $52.62B |
| Current Liabilities | Q1 2025 · Dec 31, 2024 | $51.5B |
| Total Liabilities | Q1 2025 · Mar 31, 2025 | $101.52B |
| Total Liabilities | Q1 2025 · Dec 31, 2024 | $100.9B |
| Current Assets | Q1 2025 · Mar 31, 2025 | $52.92B |
| Current Assets | Q1 2025 · Dec 31, 2024 | $51.13B |
| Total Assets | Q1 2025 · Mar 31, 2025 | $164.86B |
| Total Assets | Q1 2025 · Dec 31, 2024 | $162.86B |
| Cash And Equivalents | Q1 2025 · Dec 31, 2024 | $5.58B |
| Cash And Equivalents | Q1 2025 · Mar 31, 2024 | $5.61B |
| Shares Diluted | Q1 2025 · Mar 31, 2024 | 1.34B sh |
| Stock Repurchased | Q1 2025 · Mar 31, 2024 | $56M |
| Dividends Paid | Q1 2025 · Mar 31, 2024 | $769M |
| Capex | Q1 2025 · Mar 31, 2024 | $467M |
| Operating Cash Flow | Q1 2025 · Mar 31, 2024 | $342M |
| Eps Diluted | Q1 2025 · Mar 31, 2024 | $1.28 |
| Eps Basic | Q1 2025 · Mar 31, 2024 | $1.29 |
| Sga Expense | Q1 2025 · Mar 31, 2024 | $1.39B |
| Rd Expense | Q1 2025 · Mar 31, 2024 | $669M |
| Net Income | Q1 2025 · Mar 31, 2024 | $1.71B |
| Operating Income | Q1 2025 · Mar 31, 2024 | $1.87B |
| Revenue | Q1 2025 · Mar 31, 2024 | $19.31B |